In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has submitted a copy of the published extract of consolidated unaudited financial results for the quarter and nine months ended 31 December 2022 along with information on standalone financial results. The same was published on Wednesday, 1 February 2023 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).
The above information is a part of company’s filings submitted to BSE.
